Beyond the diagnosis.

We focus on the complexities of cancer so you can focus on the care.

OncoHealth delivers digital health solutions that reduce the physical, mental, and financial toll of cancer for everyone involved.

The first digital telehealth platform for people with cancer.​

Support before, during, and after cancer treatment.

OncoHealth is dedicated to helping health plans, employers, providers, patients, and life science researchers navigate the physical, mental and financial complexities of cancer through technology enabled services and real-world data.

Rebecca's Story

Rebecca's Story

Rebecca, a 61-year-old grandmother and substitute teacher was diagnosed with a rare form of inflammatory breast cancer, underwent chemotherapy and a modified radical mastectomy. A month after her surgery, Rebecca developed multiple lesions below her mastectomy scar which turned out to be metastatic breast cancer to the skin.
Medical Moment of Truth

Medical Moment of Truth

Rebecca and her doctors faced a choice of between the molecularly targeted therapies Piqray or Ibrance, either in combination with letrozole. Her tumor’s next-generation sequencing biomarker data revealed a PIK3CA H1047R mutation, which suggested that Piqray could be an effective treatment. But Rebecca’s medical records described a history of poorly controlled diabetes, and Piqray is known to cause or worsen high blood sugar in many patients who take it.
Personalized Treatments

Personalized Treatments

Rebecca’s health plan was presented with a request for treatment with Piqray + letrozole at a 3-month cost of $54,828. Given that Piqray-based therapy has only been proven effective in the second-line setting, OncoHealth reviewed the data and found that a first-line treatment of Ibrance + letrozole could reduce the risk of death by 34%, avoid the risk of potentially life-threatening hyperglycemia, and result in a 3-month savings of $14,397.
Advancing Oncology Research

24x7 Supportive Care

Rebecca became consumed with worry about the future. She started making excuses about attending social events and she began to feel isolated. Her health plan mentioned a new support service they were offering to all members undergoing cancer treatment called Iris. She signed up and began talking with a peer mentor who had also experienced breast cancer in midlife.
Advancing Oncology Research

Advancing Oncology Research

Leveraging de-identified, real-world data from a cohort of patients like Rebecca, life sciences researchers were able to answer questions such as do certain cohorts have better outcomes with one drug versus another; what impact does a PIK3CA mutation have on treatment effectiveness, and why was one drug prescribed over another?
Oncology Expertise

Trusted for Our Oncology Expertise by:

16

Health Plans

106

ASO Employers with over 250+ Employees

9K+

Providers

700K

Cancer Patients

Upcoming Events

Stay Current

ISPOR 2023

EVENT

ISPOR 2023
Impacting Innovation, Value, and Healthcare Decision Making

May 7-10, 2023
Boston, MA

REGISTER >

Wesley Staggs

IN THE NEWS

OncoHealth to Present How Technology Can Advance Oncology Patient Care at the 2023 ONS Congress

April 24, 2023

READ MORE >

Wesley Staggs

IN THE NEWS

OncoHealth Appoints Wesley Staggs as Chief Commercial Officer

April 12, 2023

READ MORE >

Hallie Strong Foundation

IN THE NEWS

Woman, 36, recalls being diagnosed with cervical cancer while pregnant with 1st child

February 1, 2023

READ MORE >

Susan Hoang

PRESS RELEASE

OncoHealth Appoints Susan Hoang as Chief Data & Analytics Officer

December 7, 2022

READ MORE >

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from OncoHealth.

You have Successfully Subscribed!

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from OncoHealth.

You have Successfully Subscribed!